Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio Growth (5y) (2014 - 2026)
Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.50% |
| Dec 31, 2025 | 17.32% |
| Sep 30, 2025 | 5.85% |
| Jun 30, 2025 | 9.36% |
| Mar 31, 2025 | -21.86% |
| Dec 31, 2024 | -26.41% |
| Sep 30, 2024 | -13.68% |
| Jun 30, 2024 | 95.93% |
| Mar 31, 2024 | 64.25% |
| Dec 31, 2023 | -11.44% |
| Sep 30, 2023 | -43.31% |
| Jun 30, 2023 | -46.23% |
| Mar 31, 2023 | -46.34% |
| Dec 31, 2022 | -5.95% |
| Sep 30, 2022 | -47.75% |
| Jun 30, 2022 | -47.85% |
| Mar 31, 2022 | 22.16% |
| Dec 31, 2021 | 142.34% |
| Sep 30, 2021 | -39.72% |
| Jun 30, 2021 | 11.61% |